
Pharmacally
ALYFTREK
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in ALYFTREK
Clinical TrialsVertex Reports Promising Pancreatic Function Gains With ALYFTREK in Young Children With Cystic FibrosisInterim data from Vertex Pharmaceuticals suggest improved pancreatic function in some children aged 2–5 years with cystic fibrosis treated with ALYFTREK.Fact-Checked
Health TidingsFDA Expands Vertex’s ALYFTREK and TRIKAFTA Labels to Cover 95% of CF PatientsFDA expands Vertex’s ALYFTREK and TRIKAFTA to include patients with responsive or CFTR-producing mutations, significantly widening access to CFTR modulators.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.